CD8A and cancer: Critically, we demonstrate that activated tumor antigen-specific CD8+ T cells were unable to eliminate these latent tumors, but that targeting Tregs specifically allowed the generation of more effective antitumor responses, suggesting a primacy of Tregs in protecting dormant cancer cells.